Skip to main content

Table 3 Characteristics of study patients

From: The efficacy of non-anesthesiologist-administered propofol sedation with a target-controlled infusion system during double-balloon endoscopic retrograde cholangiopancreatography

 

All patients (n = 156)

Diazepam sedation (n = 77)

Propofol sedation (n = 79)

P value

Age, mean ± SD, years

67.8 ± 13.5

68.7 ± 13.5

66.9 ± 13.6

0.256

Sex, male/female

94/62

45/32

49/30

0.648

BMI, mean ± SD, kg/m2

20.6 ± 3.4

21.1 ± 4.0

20.1 ± 2.8

0.162

Current or ex-smoker, n (%)

76 (49)

33 (43)

43 (54)

0.148

Alcohol abuse, n (%)

36 (23)

22 (29)

14 (18)

0.108

Regular narcotic/sedative use, n (%)

33 (21)

12 (16)

21 (27)

0.093

Co-morbidities, n (%)

 Heart disease

18 (12)

10 (13)

8 (10)

0.576

 Lung disease

14 (9)

6 (8)

8 (10)

0.610

 Renal disease

7 (4)

4 (5)

3 (4)

0.673

 Liver disease

15 (10)

5 (6)

10 (13)

0.192

ASA class, n (%)

   

0.235

 1

40 (26)

24 (31)

16 (20)

 

 2

95 (61)

42 (55)

53 (67)

 

 3

21 (13)

11 (14)

10 (13)

 

Bowel reconstruction methods, n (%)

   

0.309

 Child

68 (53)

39 (51)

40 (51)

 

 Roux-en-Y

53 (41)

32 (42)

37 (47)

 

 Billroth-II

8 (6)

6 (8)

2 (3)

 

Indications, n (%)

   

0.717

 Biliary stenosis

52 (33)

23 (30)

29 (37)

 

 Cholangitis

37 (24)

18 (23)

19 (24)

 

 Biliary stones

36 (23)

19 (25)

17 (22)

 

 Obstructive jaundice

4 (3)

2 (3)

2 (3)

 

 Biliary leaks

4 (3)

1 (1)

3 (4)

 

 Others

23 (15)

14 (18)

9 (11)

 

Baseline heart rate, mean ± SD, beats/minute

71.5 ± 12.4

69.7 ± 11.0

73.3 ± 13.5

0.086

Baseline SBP, mean ± SD, mmHg

122.1 ± 16.8

120.7 ± 19.5

123.5 ± 13.6

0.083

Baseline oxygen saturation, mean ± SD, %

97.5 ± 1.3

97.3 ± 1.4

97.6 ± 1.2

0.110

  1. SD standard deviation, BMI body mass index, ASA American Society of Anesthesiologists, SBP systolic blood pressure